Sage Therapeutics (NASDAQ:SAGE) Upgraded at Wall Street Zen
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Friday. A number of other analysts have also weighed in on SAGE. Needham & Company LLC reiterated a “hold” rating on shares of Sage Therapeutics in […]
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Friday. A number of other analysts have also weighed in on SAGE. Needham & Company LLC reiterated a “hold” rating on shares of Sage Therapeutics in […]
